|
|
||||||||

* Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
Tuberculosis Research Center, Chennai, India
Patent lymphatic filariasis is characterized by a profound down-regulation of immune responses with both parasite Ag-specific tolerance and bystander suppression. Although this down-regulation is confined to the Th1 arm of the immune system in response to parasite Ag, we hypothesized a more generalized suppression in response to live parasites. Indeed, when we examined the cytokine profile of a cohort of filaria-infected (n = 10) and uninfected (n = 10) individuals in response to live infective-stage larvae or microfilariae of Brugia malayi, we found significant impairment of both Th1 and Th2 cytokines characterized by diminished production of IFN-
, TNF-
, IL-4, IL-5, and IL-10 in infected patients. The molecular basis of this impaired Th1/Th2 response was examined, and we identified three major networks of immunoregulation and tolerance. First, impaired induction of T-bet and GATA-3 mRNA underlies the Th1/Th2 deficiency in infected individuals. Second, regulatory networks, as evidenced by significantly increased expression of Foxp3 (natural regulatory T cell marker) and regulatory effectors such as TGF-
, CTLA-4, PD-1, ICOS, and indoleamine 2,3-dioxygenase play an important role in immunosuppression. Third, the compromise of effector T cell function is mediated by the enhanced induction of anergy-inducing factors cbl-b, c-cbl (cbl is abbreviation for Casitas B lymphoma), Itch, and Nedd4. Indeed, blocking CTLA-4 or neutralizing TGF-
restored the ability to mount Th1/Th2 responses to live parasites and reversed the induction of anergy-inducing factors. Hence, we conclude that a profound impairment of live parasite-specific Th1 and Th2 immune responses occurs in lymphatic filariasis that is governed at the transcriptional level by a complex interplay of inhibitory mediators.
This article has been cited by other articles:
![]() |
S. Metenou, B. Dembele, S. Konate, H. Dolo, S. Y. Coulibaly, Y. I. Coulibaly, A. A. Diallo, L. Soumaoro, M. E. Coulibaly, D. Sanogo, et al. Patent Filarial Infection Modulates Malaria-Specific Type 1 Cytokine Responses in an IL-10-Dependent Manner in a Filaria/Malaria-Coinfected Population J. Immunol., July 15, 2009; 183(2): 916 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Imarai, E. Candia, C. Rodriguez-Tirado, J. Tognarelli, M. Pardo, T. Perez, D. Valdes, S. Reyes-Cerpa, P. Nelson, C. Acuna-Castillo, et al. Regulatory T Cells Are Locally Induced during Intravaginal Infection of Mice with Neisseria gonorrhoeae Infect. Immun., December 1, 2008; 76(12): 5456 - 5465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. McSorley, Y. M. Harcus, J. Murray, M. D. Taylor, and R. M. Maizels Expansion of Foxp3+ Regulatory T Cells in Mice Infected with the Filarial Parasite Brugia malayi J. Immunol., November 1, 2008; 181(9): 6456 - 6466. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rausch, J. Huehn, D. Kirchhoff, J. Rzepecka, C. Schnoeller, S. Pillai, C. Loddenkemper, A. Scheffold, A. Hamann, R. Lucius, et al. Functional Analysis of Effector and Regulatory T Cells in a Parasitic Nematode Infection Infect. Immun., May 1, 2008; 76(5): 1908 - 1919. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Taylor, A. Harris, S. A. Babayan, O. Bain, A. Culshaw, J. E. Allen, and R. M. Maizels CTLA-4 and CD4+CD25+ Regulatory T Cells Inhibit Protective Immunity to Filarial Parasites In Vivo J. Immunol., October 1, 2007; 179(7): 4626 - 4634. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Beiting, L. F. Gagliardo, M. Hesse, S. K. Bliss, D. Meskill, and J. A. Appleton Coordinated Control of Immunity to Muscle Stage Trichinella spiralis by IL-10, Regulatory T Cells, and TGF-beta J. Immunol., January 15, 2007; 178(2): 1039 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Myint, R Sahay, S Mon, V R Saravanan, V Narendran, and B Dhillon "Worm in the eye": the rationale for treatment of DUSN in south India Br J Ophthalmol, September 1, 2006; 90(9): 1125 - 1127. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |